Sterility Testing Market Worth 941.0 Million USD by 2021 – Exclusive Report by MarketsandMarkets™

Northbrook, USA, 2021-Sep-07 — /EPR Network/ — According to a new market research report “Sterility Testing Market by Product (Instruments, Services, Kits and Reagents), Test (Membrane Filtration Sterility Testing, Direct Inoculation Sterility Testing), Application (Pharmaceutical & Biotechnology, Medical Devices) – Global Forecasts to 2021″, published by MarketsandMarkets, The global Sterility Testing Market is expected to reach USD 941.0 Million by 2021 from USD 528.0 Million in 2016, at a CAGR of 12.3% from 2016 to 2021.

Browse 67 market data tables and 35 figures spread through 124 pages and in-depth TOC on “Sterility Testing Market”

Growth in the pharmaceutical and biotechnology industries, increase in the number of new drug launches, and increasing R&D in life science research are the key factors driving the growth of this market. The market is further driven by factors such as increasing government support for pharmaceutical and biotechnology industries. On the other hand, the high degree of market consolidation is a major factor restraining the growth of this market.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=208866931

On the basis of product, the Sterility Testing Market is segmented into kits and reagents, instruments, and services. The kits and reagents segment is expected to account for the largest share of the market. The large share of the kits and reagents segment can be attributed to the requirement of the repeat purchase of these products, coupled with the increasing preference for kit-based testing.

On the basis of test, the Sterility Testing Market is segmented into membrane filtration, direct inoculation, and other sterility tests. In 2016, the membrane filtration segment accounted for the largest share. The large share of this segment can primarily be attributed to rapid growth in the pharmaceutical and biotechnology end-use industry.

On the basis of application, the Sterility Testing Market is segmented into pharmaceutical and biological manufacturing, medical devices manufacturing, and others applications. In 2016, the pharmaceutical and biological manufacturing segment is expected to account for the largest share primarily due to the rapid growth in the pharma and biotech industries.

On the basis of region, the global Sterility Testing Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The Asian market will witness the highest growth during the forecast period, primarily due to the increasing expenditure on life science research in the region and growing trend of pharmaceutical outsourcing to Asian countries like India and China.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=208866931

Some of the major players operating in the Sterility Testing Market are Merck KGaA (Germany), Charles River Laboratories International, Inc. (U.S.), bioMérieux SA (France), SGS S.A. (Switzerland), Sartorius AG (Germany), WuXi AppTec (China), and Thermo Fisher Scientific, Inc. (U.S.).

Browse Related Reports:

Biological Safety Testing Market by Application (Stem Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), & Test (Bioburden, Endotoxin, Cell Line Authentication, Residual Contamination, Adventitious Agents) – Global Forecast to 2019.

http://www.marketsandmarkets.com/Market-Reports/biologics-safety-testing-market-34624144.html

Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) – Forecast to 2019.

http://www.marketsandmarkets.com/Market-Reports/bioburden-testing-market-17983056.html

About MarketsandMarkets:

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No: 1-888-600-6441.
Email: sales@marketsandmarkets.com

Content Source: https://www.marketsandmarkets.com/PressReleases/sterility-testing.asp